{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:00Z","timestamp":1786649700451,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>WATCHMAN (Boston Scientific, Plymouth, MN, USA) is the most commonly utilized left atrial appendage occlusion device. Although increased operator experience has led to a significant decline in reported complications, serious and potentially fatal events can still occur. We present a case of WATCHMAN device embolization that was identified using transesophageal echocardiography shortly after device deployment, along with the subsequent management and retrieval of the device.<\/jats:p>","DOI":"10.4103\/aca.aca_263_24","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T12:00:45Z","timestamp":1752062445000},"page":"313-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["WATCHMAN Gone Astray, Catastrophic Mitral Regurgitation Following Device Dislodgement"],"prefix":"10.4103","volume":"28","author":[{"given":"Basil","family":"Jouryyeh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ministry of Health, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beshara","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"R1-20250709","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"R2-20250709","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/14779072.2023.2160319","article-title":"Atrial fibrillation and stroke","volume":"21","author":"Choi","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R3-20250709","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"R4-20250709","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"R5-20250709","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R6-20250709","first-page":"667","article-title":"Left atrial appendage exclusion system for stroke prevention in atrial fibrillation: A percutaneous device delivery approach","volume":"56","author":"Lerakis","year":"2008","journal-title":"Minerva Cardioangiol"},{"key":"R7-20250709","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2005.03.042","article-title":"Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials","volume":"46","author":"Ostermayer","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250709","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1053\/j.jvca.2016.06.012","article-title":"Anesthesia and transesophageal echocardiography for WATCHMAN device implantation","volume":"30","author":"Mitrev","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R9-20250709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250709","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"R11-20250709","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/jce.15909","article-title":"Watchman device migration and embolization: A report from the NCDR LAAO Registry","volume":"34","author":"Friedman","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R12-20250709","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/HCO.0000000000000367","article-title":"Percutaneous left atrial appendage closure: Current state of the art","volume":"32","author":"Jazayeri","year":"2017","journal-title":"Curr Opin Cardiol"},{"key":"R13-20250709","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ccd.25891","article-title":"Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug","volume":"86","author":"Aminian","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"R14-20250709","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/jce.15942","article-title":"Early and late Watchman device migration and embolization: Insights from the NCDR LAAO registry","volume":"34","author":"Lin","year":"2023","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_263_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:13Z","timestamp":1786647433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_263_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_263_24","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-12-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}